Anders D. Hove, Director at Anacor Pharmaceuticals, Inc. (ANAC), sold 707,762 shares at $99.41 ($70.5M) on 2016-05-16, disclosed to the SEC on 2016-05-18.
Open-market sale of $70.5M ANAC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.93 | 72,385 | $7.2M | 10.2% |
| 2 | $98.93 | 72,385 | $7.2M | 10.2% |
| 3 | $99.41 | 199,865 | $19.9M | 28.2% |
| 4 | $99.41 | 199,865 | $19.9M | 28.2% |
| 5 | $100.60 | 81,631 | $8.2M | 11.7% |
| 6 | $100.60 | 81,631 |
| $8.2M |
| 11.7% |
| Total | $99.59 avg | 707,762 | $70.5M | 100% |
| Filing → |
| ANAC | SELL | 2015-12-15 | $4.7M | — | Filing → |
| ANAC | SELL | 2015-11-12 | $10.4M | — | Filing → |
| EDGE | BUY | 2015-10-08 | $5.0M | — | Filing → |